hotspot -WSS

hotspot

author：hotspot 2025-09-03 03:41:08 - browse：513

Sen. Bernie Sanders, I-Vt., chairman of the Senate Health, Education, Labor, and Pensions Committee listens during a hearing on Capitol Hill in Washington – politics and policy coverage from STAT — Senate health committee Chair Bernie Sanders (I-Vt.) wants to reward new medicines with prize money. Jose Luis Magana/AP

WASHINGTON — Sen. Bernie Sanders (I-Vt.) will finally get a study of his proposal to do away with drug patents and other intellectual property protections in favor of rewarding inventions with prize money. Sanders has been pushing the prize approach since he was a House representative, many years ago.

The measure directing the National Academies of Sciences, Engineering and Medicine to study the idea was added to the Pandemic All-Hazards and Preparedness Act a day before Sander’s health committee passed the bill. Three Republicans voted against the overall bill, which renews several federal biodefense and pandemic-preparedness programs.

Though Democrats last year passed historic legislation to let Medicare negotiate drug prices and cap seniors’ annual out-of-pocket drug costs, Sanders is demanding more drug price controls. He is delaying President Biden’s pick for running the National Institutes of Health until the president releases a plan to control drug prices.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Medicare proposal to cover medical devices draws a mixed reaction
Next article： Free Covid tests will again be offered to all U.S. households

Wikipedia

WSS

The struggle to figure out which patients 'deserve' Wegovy

Bankrupt Pear's prescription app helped MassHealth save money, data suggests

Readout LOUD Podcast: Legal insider trading, booming biotech stocks

Kristina Burow of ARCH Venture Partners shares her next big bets STAT

Scientists unlock the key to scar

Kristina Burow of ARCH Venture Partners shares her next big bets STAT

knowledge

hotspot

explore

The cancer drug shortage isn’t new — and neither are the solutions

Kristina Burow of ARCH Venture Partners shares her next big bets STAT

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

What happened to the House vote on health price transparency?

Heart attack and stroke risk calculators need revising

RaDonda Vaught to speak at CommonSpirit event on patient safety

Drug repurposing or repositioning? The language matters

An inside look at PIPEs, biotech's buzzy new financing tool

Continuity nursing helped my family in our darkest PICU moments

In search for therapies for solid tumors, companies turn to claudin

focus

Readout LOUD Podcast: Legal insider trading, booming biotech stocks

Fed up with FDA, ALS advocates consider a take

FDA panel to weigh safety of artificial wombs for preterm births

Grad students accuse University of California of wage theft

PBMs drew scrutiny in House hearing — and so did pharma

Fed up with FDA, ALS advocates consider a take

hotspot

Wikipedia

focus

focus